Petina Musara

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

Jared M. Baeten, Thesla Palanee‐Phillips, Nyaradzo Mgodi et al. · The Lancet HIV · 2021 · 111 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +16

Disclosure of pharmacokinetic drug results to understand nonadherence

Ariane van der Straten, Elizabeth Montgomery, Petina Musara et al. · AIDS · 2015 · 76 citations

Public Health, Pharmacokinetics, Pharmacology +12

Acceptability of a long‐acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076)

Elizabeth E. Tolley, Sue Li, Sahar Z. Zangeneh et al. · Journal of the International AIDS Society · 2019 · 61 citations · Full text

Public Health, Preventive Medicine, Contraception +14

Misreporting of Product Adherence in the MTN-003/VOICE Trial for HIV Prevention in Africa: Participants’ Explanations for Dishonesty

Elizabeth Montgomery, Barbara Mensch, Petina Musara et al. · AIDS and Behavior · 2016 · 59 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +11

End‐user preference for and choice of four vaginally delivered<scp>HIV</scp>prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study

Elizabeth Montgomery, Mags Beksinska, Nyaradzo Mgodi et al. · Journal of the International AIDS Society · 2019 · 56 citations · Full text

Public Health, Health Sciences, Preventive Medicine +17